John Mendelson

3.9k total citations
71 papers, 2.8k citations indexed

About

John Mendelson is a scholar working on Toxicology, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, John Mendelson has authored 71 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Toxicology, 27 papers in Cellular and Molecular Neuroscience and 18 papers in Clinical Psychology. Recurrent topics in John Mendelson's work include Forensic Toxicology and Drug Analysis (29 papers), Neurotransmitter Receptor Influence on Behavior (25 papers) and Psychedelics and Drug Studies (16 papers). John Mendelson is often cited by papers focused on Forensic Toxicology and Drug Analysis (29 papers), Neurotransmitter Receptor Influence on Behavior (25 papers) and Psychedelics and Drug Studies (16 papers). John Mendelson collaborates with scholars based in United States, Switzerland and France. John Mendelson's co-authors include Reese T. Jones, Matthew J. Baggott, Debra Harris, Robert A. Upton, E. Thomas Everhart, Gantt P. Galloway, Peyton Jacob, Susette Welm, J H Mendelson and Vernon D. Patch and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Immunology and Journal of the American College of Cardiology.

In The Last Decade

John Mendelson

71 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Mendelson United States 31 862 761 725 664 479 71 2.8k
Johan Duflou Australia 33 601 0.7× 671 0.9× 794 1.1× 513 0.8× 445 0.9× 120 3.6k
Karen Miotto United States 33 1.2k 1.3× 944 1.2× 506 0.7× 722 1.1× 635 1.3× 76 4.0k
W. D. Darwin United States 36 508 0.6× 432 0.6× 1.6k 2.3× 1.2k 1.8× 278 0.6× 60 3.2k
Diana G. Wilkins United States 38 1.4k 1.6× 366 0.5× 1000 1.4× 556 0.8× 425 0.9× 111 4.3k
Kim Wolff United Kingdom 28 242 0.3× 537 0.7× 553 0.8× 503 0.8× 296 0.6× 120 2.4k
E. J. Cone United States 20 288 0.3× 911 1.2× 766 1.1× 644 1.0× 120 0.3× 24 2.1k
Gisela Skopp Germany 36 478 0.6× 260 0.3× 2.0k 2.7× 1.2k 1.9× 395 0.8× 193 4.3k
Steven B. Karch United States 32 491 0.6× 278 0.4× 960 1.3× 432 0.7× 324 0.7× 97 2.9k
Jermaine D. Jones United States 25 559 0.6× 1.0k 1.4× 285 0.4× 336 0.5× 142 0.3× 79 2.2k
A. Hamid Ghodse United Kingdom 27 372 0.4× 429 0.6× 691 1.0× 401 0.6× 586 1.2× 79 1.9k

Countries citing papers authored by John Mendelson

Since Specialization
Citations

This map shows the geographic impact of John Mendelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Mendelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Mendelson more than expected).

Fields of papers citing papers by John Mendelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Mendelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Mendelson. The network helps show where John Mendelson may publish in the future.

Co-authorship network of co-authors of John Mendelson

This figure shows the co-authorship network connecting the top 25 collaborators of John Mendelson. A scholar is included among the top collaborators of John Mendelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Mendelson. John Mendelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Baggott, Matthew J., Jeremy Coyle, Gantt P. Galloway, et al.. (2016). MDMA Impairs Response to Water Intake in Healthy Volunteers. Advances in Pharmacological Sciences. 2016. 1–11. 10 indexed citations
3.
Garza, Richard De La, Thomas F. Newton, John Mendelson, et al.. (2013). Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 50. 44–52. 4 indexed citations
4.
Baggott, Matthew J., et al.. (2011). Mechanisms and Genetics of Antipsychotic-Associated Weight Gain. Clinical Pharmacology & Therapeutics. 90(1). 179–183. 38 indexed citations
5.
Herbst, Ellen, Debra Harris, E. Thomas Everhart, et al.. (2011). Cocaethylene formation following ethanol and cocaine administration by different routes.. Experimental and Clinical Psychopharmacology. 19(2). 95–104. 45 indexed citations
6.
Mendelson, John, Matthew J. Baggott, Keith Flower, & Gantt P. Galloway. (2011). Developing Biomarkers for Methamphetamine Addiction. Current Neuropharmacology. 9(1). 100–103. 10 indexed citations
7.
Galloway, Gantt P., et al.. (2010). A Simple, Novel Method for Assessing Medication Adherence. Journal of Addiction Medicine. 5(3). 170–174. 23 indexed citations
8.
Baggott, Matthew J., Earth Erowid, Fire Erowid, Gantt P. Galloway, & John Mendelson. (2010). Use patterns and self-reported effects of Salvia divinorum: An internet-based survey. Drug and Alcohol Dependence. 111(3). 250–256. 65 indexed citations
9.
Coyle, Jeremy, et al.. (2010). A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction. Clinical Pharmacology & Therapeutics. 89(2). 276–282. 68 indexed citations
10.
Baggott, Matthew J., et al.. (2008). The effects of inhaled L-methamphetamine on athletic performance while riding a stationary bike: a randomised placebo-controlled trial. British Journal of Sports Medicine. 43(11). 832–835. 10 indexed citations
11.
Mendelson, John, Keith Flower, Mark J. Pletcher, & Gantt P. Galloway. (2008). Addiction to prescription opioids: Characteristics of the emerging epidemic and treatment with buprenorphine.. Experimental and Clinical Psychopharmacology. 16(5). 435–441. 44 indexed citations
12.
Mendelson, John, et al.. (2006). Human pharmacology of the methamphetamine stereoisomers. Clinical Pharmacology & Therapeutics. 80(4). 403–420. 102 indexed citations
13.
Harris, Debra, Matthew J. Baggott, Jack H. Mendelson, John Mendelson, & Reese T. Jones. (2002). Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology. 162(4). 396–405. 169 indexed citations
14.
Mendelson, John, Naoto Uemura, Laeben Lester, et al.. (2001). Pharmacologic interactions between transdermal selegiline and cocaine. Clinical Pharmacology & Therapeutics. 69(2). 1 indexed citations
15.
Uemura, Naoto, Laeben Lester, R. Nath, et al.. (2001). Cocaine levels in sweat patches decline over time. Clinical Pharmacology & Therapeutics. 69(2). 1 indexed citations
16.
Mendelson, John, Reese T. Jones, Susette Welm, James A. Brown, & Steven L. Batki. (1997). Buprenorphine and naloxone interactions in methadone maintenance patients. Biological Psychiatry. 41(11). 1095–1101. 46 indexed citations
17.
Eisenberg, Mark J., et al.. (1996). Immediate Effects of Intravenous Cocaine on the Thoracic Aorta and Coronary Arteries. CHEST Journal. 110(1). 147–154. 11 indexed citations
18.
Mendelson, John, et al.. (1996). Buprenorphine and naloxone interactions in opiate-dependent volunteers*. Clinical Pharmacology & Therapeutics. 60(1). 105–114. 66 indexed citations
19.
Mendelson, John, Reese T. Jones, Robert A. Upton, & Peyton Jacob. (1995). Methamphetamine and ethanol interactions in humans*. Clinical Pharmacology & Therapeutics. 57(5). 559–568. 97 indexed citations
20.
Mendelson, John, et al.. (1979). Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 53(1). 31–5. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026